| Description |
1 online resource |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Note |
Includes index. |
|
Vendor-supplied metadata. |
| Contents |
Cover; Title Page; Copyright Page; Contents; List of Contributors; Foreword; Preface; Chapter 1 -- New Trends in the Antimicrobial Agents Delivery Using Nanoparticles; 1 -- Introduction; 2 -- Nanoparticles for drug-delivery systems; 3 -- Polymeric carriers used to prepare nanoparticles as drug carriers; 3.1 -- Natural Polymers; 3.1.1 -- Alginates; 3.1.2 -- Chitosan; 3.1.3 -- Gelatin; 3.2 -- Semisynthetic Polymers; 3.3 -- Synthetic Biodegradable Polymers; 3.3.1 -- Poly(esters); 3.3.2 -- Poly(anhydrides); 3.3.3 -- Poly-[epsilon]-Caprolactones; 3.3.4 -- Poly(orthoesters) |
|
5.1.2.1 -- Aluminium oxide nanoparticles5.1.2.2 -- Magnesium oxide nanoparticles; 5.1.2.3 -- Copper oxide nanoparticles; 5.1.2.4 -- Zinc oxide nanoparticles; 5.1.2.5 -- Titanium dioxide nanoparticles; 5.1.2.6 -- Nitric oxide nanoparticles; 5.1.2.7 -- Iron oxide; 5.2 -- Organic Nanoparticles; 5.2.1 -- Poly-[epsilon]-lysine; 5.2.2 -- Triclosan; 5.2.3 -- Quaternary Ammonium Compounds; 5.2.4 -- Polyethyleneimine; 5.2.5 -- Cationic Quaternary Polyelectrolytes; 5.2.6 -- N-Halamine compounds; 5.2.7 -- Polysiloxanes; 5.2.8 -- Benzoic Acid, Phenol, and P-Hydroxy Benzoate Esters; 5.2.9 -- Benzaldehyde |
|
4 -- Recent trends in nanoparticulate drug-delivery systems4.1 -- Biological Transport of Nanoparticles; 4.2 -- Ideal Properties of Nanoparticle Delivery Systems; 4.3 -- Types of Nanoparticulate Drug Delivery System; 4.3.1 -- Polymeric Micelles; 4.3.2 -- Microemulsion; 4.3.3 -- Liposomes; 4.3.4 -- Solid Lipid Nanoparticles; 4.3.5 -- Lipid Nanocapsules; 4.3.6 -- Dendrimers; 4.3.7 -- Chitosan-Based Nanoparticulate; 5 -- Application of nanoparticles/diverse and emerging trends in nanoparticles applications; 6 -- Concluding remarks and future prospects; References |
|
Chapter 2 -- Nanostructures as Antimicrobial Therapeutics1 -- Introduction; 2 -- Nanoparticles as antimicrobial agents; 2.1 -- What Are Nanostructures?; 2.2 -- Distinctive Properties of Nanoparticles; 2.2.1 -- Appropriate Size; 2.2.2 -- Surface Chemistry (Functionalizable Structure); 2.2.3 -- Chemical Stability; 2.2.4 -- High Surface Area to Mass Ratio; 2.2.5 -- High Reactivity; 2.2.6 -- Biosafety and Biocompatibility; 3 -- Mode of action of nanoparticles; 3.1 -- Cell Membrane Damage; 3.2 -- Release of Toxic Ions; 3.3 -- Interruption of Electron Transport, Protein Oxidation, and Membrane Collapse |
|
3.4 -- Generation of Reactive Oxygen Species (ROS)3.5 -- Photothermal Damage; 4 -- Nanoparticles use in antimicrobial therapy; 4.1 -- As Conjugates to Enhance Activity of Already Existing Antibiotics; 4.2 -- As Antimicrobial Agents; 4.3 -- As Encapsulating Agents for Efficient Drug Delivery; 4.4 -- For Surface Coating in Medical Devices; 4.5 -- As Antimicrobial Nanovaccines; 4.5.1 -- Nanoparticles for Vaccine Delivery; 4.5.2 -- Nanoadjuvants; 5 -- Types of nanoparticles; 5.1 -- Inorganic; 5.1.1 -- Metals; 5.1.1.1 -- Silver nanoparticles; 5.1.1.2 -- Gold nanoparticles; 5.1.2 -- Metal Oxide Nanoparticles |
|
5.2.10 -- Quaternary Phosphonium or Sulfonium Groups |
| Bibliography |
Includes bibliographical references and index. |
| Subject |
Anti-infective agents.
|
|
Nanostructured materials.
|
|
Anti-Infective Agents |
|
Nanostructures |
|
Antiinfectieux.
|
|
Nanomatériaux.
|
|
MEDICAL -- Pharmacology.
|
|
Anti-infective agents
|
|
Nanostructured materials
|
| Added Author |
Grumezescu, Alexandru Mihai, editor.
|
| Other Form: |
Print version: Antimicrobial nanoarchitectonics. Amsterdam, Netherlands : Elsevier, [2017] 9780323527330 0323527337 (OCoLC)960845576 |
| ISBN |
9780323527347 (electronic bk.) |
|
0323527345 (electronic bk.) |
|
9780323527330 |
|
0323527337 |
| Standard No. |
40027455223 |
|
CHVBK 49978409X |
|
CHBIS 011069694 |
|
AU@ 000060417265 |
|
GBVCP 89784520X |
|
UKMGB 018299216 |
|
